Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR)

被引:2
|
作者
Devpura, S. [1 ]
Siddiqui, M. S. [1 ]
Chen, D. [1 ]
Liu, D. [1 ]
Li, H. [1 ]
Kumar, S. [1 ]
Gordon, J. [1 ]
Ajlouni, M. [1 ]
Movsas, B. [1 ]
Chetty, I. J. [1 ]
机构
[1] Henry Ford Hlth Syst, Detroit, MI 48202 USA
来源
XVII INTERNATIONAL CONFERENCE ON THE USE OF COMPUTERS IN RADIATION THERAPY (ICCR 2013) | 2014年 / 489卷
关键词
MONTE-CARLO; RADIATION-THERAPY; PHOTON BEAMS; ALGORITHM; VMC;
D O I
10.1088/1742-6596/489/1/012007
中图分类号
O59 [应用物理学];
学科分类号
摘要
The purpose of this study was to systematically evaluate dose distributions computed with 5 different dose algorithms for patients with lung cancers treated using stereotactic ablative body radiotherapy (SABR). Treatment plans for 133 lung cancer patients, initially computed with a 1D-pencil beam (equivalent-path-length, EPL-1D) algorithm, were recalculated with 4 other algorithms commissioned for treatment planning, including 3-D pencil-beam (EPL-3D), anisotropic analytical algorithm (AAA), collapsed cone convolution superposition (CCC), and Monte Carlo (MC). The plan prescription dose was 48 Gy in 4 fractions normalized to the 95% isodose line. Tumors were classified according to location: peripheral tumors surrounded by lung (lung-island, N=39), peripheral tumors attached to the rib-cage or chest wall (lung-wall, N=44), and centrally-located tumors (lung-central, N=50). Relative to the EPL-1D algorithm, PTV D95 and mean dose values computed with the other 4 algorithms were lowest for "lung-island" tumors with smallest field sizes (3-5 cm). On the other hand, the smallest differences were noted for lung-central tumors treated with largest field widths (7-10 cm). Amongst all locations, dose distribution differences were most strongly correlated with tumor size for lung-island tumors. For most cases, convolution/superposition and MC algorithms were in good agreement. Mean lung dose (MLD) values computed with the EPL-1D algorithm were highly correlated with that of the other algorithms (correlation coefficient =0.99). The MLD values were found to be similar to 10% lower for small lung-island tumors with the model-based (conv/superposition and MC) vs. the correction-based (pencil-beam) algorithms with the model-based algorithms predicting greater low dose spread within the lungs. This study suggests that pencil beam algorithms should be avoided for lung SABR planning. For the most challenging cases, small tumors surrounded entirely by lung tissue (lung-island type), a Monte-Carlo-based algorithm may be warranted.
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Developing a class solution for Prostate Stereotactic Ablative Body Radiotherapy (SABR) using Volumetric Modulated Arc Therapy (VMAT)
    Murray, Louise J.
    Cosgrove, Vivian
    Lilley, John
    Sykes, Jonathan
    Thompson, Christopher M.
    Franks, Kevin
    Sebag-Montefiore, David
    Henry, Ann M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 110 (02) : 298 - 302
  • [42] Oligometastatic cancer: stereotactic ablative radiotherapy for patients affected by isolated body metastasis
    Lancia, Andrea
    Ingrosso, Gianluca
    Carosi, Alessandra
    Di Murro, Luana
    Giudice, Emilia
    Cicchetti, Sara
    Morelli, Pasquale
    di Cristino, Daniela
    Bruni, Claudia
    Murgia, Alessandra
    Cancelli, Alessandro
    Turturici, Irene
    Iadevaia, Anjali
    Ponti, Elisabetta
    Santoni, Riccardo
    ACTA ONCOLOGICA, 2017, 56 (11) : 1621 - 1625
  • [43] Dosimetric comparison of brachyablation and stereotactic ablative body radiotherapy in the treatment of liver metastasis
    Pennington, J. Daniel
    Park, Sang June
    Abgaryan, Narine
    Banerjee, Robyn
    Lee, Percy P.
    Loh, Christopher
    Lee, Edward
    Demanes, D. Jeffrey
    Kamrava, Mitchell
    BRACHYTHERAPY, 2015, 14 (04) : 537 - 542
  • [44] Stereotactic Body Radiotherapy for Early Stage Lung Cancer
    Nagata, Yasushi
    CANCER RESEARCH AND TREATMENT, 2013, 45 (03): : 155 - 161
  • [45] Ablative or Palliative Stereotactic Body Radiotherapy with Helical Tomotherapy for Primary or Metastatic Lung Tumor
    Marcenaro, Michela
    Vagge, Stefano
    Belgioia, Leliana
    Agnese, Dario
    Lamanna, Giorgio
    Mantero, Elisa
    Gusinu, Marco
    Garelli, Stefania
    Cavagnetto, Francesca
    Agostinelli, Stefano
    Corvo, Renzo
    ANTICANCER RESEARCH, 2013, 33 (02) : 655 - 660
  • [46] Single-Fraction Stereotactic Ablative Body Radiotherapy to the Lung- The Knockout Punch
    Tjong, M. C.
    Louie, A., V
    Singh, A. K.
    Videtic, G.
    Stephans, K.
    Plumridge, N.
    Harden, S.
    Slotman, B. J.
    Alongi, F.
    Guckenberger, M.
    Siva, S.
    CLINICAL ONCOLOGY, 2022, 34 (05) : E183 - E194
  • [47] Patient reported outcomes following video assisted thoracoscopic (VATS) resection or stereotactic ablative body radiotherapy (SABR) for treatment of non-small cell lung cancer: protocol for an observational pilot study (LiLAC)
    Pompili, Cecilia
    Franks, Kevin N.
    Brunelli, Alessandro
    Hussain, Yusuf S.
    Holch, Patricia
    Callister, Matthew E.
    Robson, Jonathan M.
    Papagiannopoulos, Kostas
    Velikova, Galina
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2703 - 2713
  • [48] Definitive treatment of early-stage non-small cell lung cancer with stereotactic ablative body radiotherapy in a community cancer center setting
    Heal, Cory
    Ding, William
    Lamond, John
    Wong, Michael
    Lanciano, Rachelle
    Su, Stacy
    Yang, Jun
    Feng, Jing
    Arrigo, Stephen
    Markiewicz, Deborah
    Hanlon, Alexandra
    Brady, Luther
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [49] The impact of abdominal compression on outcome in patients treated with stereotactic body radiotherapy for primary lung cancer
    Mampuya, Wambaka Ange
    Matsuo, Yukinori
    Ueki, Nami
    Nakamura, Mitsuhiro
    Mukumoto, Nobutaka
    Nakamura, Akira
    Iizuka, Yusuke
    Kishi, Takahiro
    Mizowaki, Takashi
    Hiraoka, Masahiro
    JOURNAL OF RADIATION RESEARCH, 2014, 55 (05) : 934 - 939
  • [50] Survival Impact of Cardiac Dose Following Lung Stereotactic Body Radiotherapy
    Wong, Olive Y.
    Yau, Vivian
    Kang, Julie
    Glick, Daniel
    Lindsay, Patricia
    Le, Lisa W.
    Sun, Alexander
    Bezjak, Andrea
    Cho, B. C. John
    Hope, Andrew
    Giuliani, Meredith
    CLINICAL LUNG CANCER, 2018, 19 (02) : E241 - E246